| 000 | 01689 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517002627.0 | ||
| 264 | 0 | _c20160621 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1776-260X | ||
| 024 | 7 |
_a10.1007/s11523-014-0345-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCinci, Marc | |
| 245 | 0 | 0 |
_aTargeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack. _h[electronic resource] |
| 260 |
_bTargeted oncology _cSep 2015 |
||
| 300 |
_a405-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies _xchemistry |
| 650 | 0 | 4 |
_aAntigens, CD _xgenetics |
| 650 | 0 | 4 |
_aCD55 Antigens _xmetabolism |
| 650 | 0 | 4 |
_aCD59 Antigens _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aComplement C3 _xmetabolism |
| 650 | 0 | 4 | _aComplement System Proteins |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Cofactor Protein _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Transferrin _xgenetics |
| 650 | 0 | 4 |
_aTransferrin _xmetabolism |
| 700 | 1 | _aMamidi, Srinivas | |
| 700 | 1 | _aLi, Wenhan | |
| 700 | 1 | _aFehring, Volker | |
| 700 | 1 | _aKirschfink, Michael | |
| 773 | 0 |
_tTargeted oncology _gvol. 10 _gno. 3 _gp. 405-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11523-014-0345-6 _zAvailable from publisher's website |
| 999 |
_c24352972 _d24352972 |
||